Cognistar 60 mg Injection 1's is a member of a class of drugs known as central nervous system agents or neuroprotective agents. It is used to treat a variety of conditions such as cranial injury (head injury), cerebrovascular pathological sequelae, and aprosexia in dementia. Cerebroprotein Hydrolysate, a neurotrophic agent found in Cognistar 60 Injection, acts on the central nervous system in a variety of ways to preserve neurons and enhance memory, attention, and alertness. A trained medical practitioner will deliver Cognistar 60 Injection. Certain typical adverse effects, including headache, nausea, vertigo, agitation, increased perspiration, fever, confusion, hallucinations, and flu-like symptoms, may occasionally occur.Disclaimer:For more information contact your physician.